ANASTASIOS GIANAKAKOS - 29 Dec 2021 Form 4 Insider Report for LianBio (LIAN)

Role: Director
Signature: By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol: LIAN
Transactions as of: 29 Dec 2021
Net transactions value: +$237,197
Form type: 4
Filing time: 03 Jan 2022, 15:20:13 UTC
Previous filing: 29 Oct 2021
Next filing: 27 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIAN	Ordinary Shares	Options Exercise	$237,197	+36,548		$6.49	36,548	29 Dec 2021	Direct
holding	LIAN	Ordinary Shares						309,623	29 Dec 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LIAN	Stock Option (Right to Buy)	Options Exercise	$0	-36,548	-25%	$0.000000	109,647	29 Dec 2021	Ordinary Shares	36,548	$6.49	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares underlying the option vested and became exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.